A clinical trial on KUPPAIMENI CHOORANAM in the management of IRAIPPU IRUMAL(BRONCHIAL ASTHMA)
Phase 2
Completed
- Conditions
- Health Condition 1: J459- Other and unspecified asthma
- Registration Number
- CTRI/2021/02/031231
- Lead Sponsor
- Government Siddha Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1.Patient with the symptoms of dry cough, recurrent attacks of dyspnoea,hoarseness of voice,tightness of chest,profuse sweating and wheezing
2.History of allergens, climatic changes
3.Patients who are willing to take radiological investigation and provide blood for lab investigation.
Exclusion Criteria
1.Cardiac Diseases
2.Chronic allergic bronchitis
3.Tuberculosis
4.COPD
5.Pregnancy and Lactating mother
6.Restrictive airway disease
7.Status Asthmaticus
8.Systemic Hypertension
9.Autoimmune Diseases
10.Drugs and Chemicals
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method If during treatment or after treatment reduction of the following symptoms <br/ ><br>1.Dry cough <br/ ><br>2.Recurrent attacks of dyspnoea <br/ ><br>3.Hoarseness of voice <br/ ><br>4.Tightness of chest <br/ ><br>5.Profuse sweating <br/ ><br>6.WheezingTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method 1.To evaluate the pharmacological activities <br/ ><br>2.Study about the prevalence of Iraippu Irumal in relation between diet and life styles <br/ ><br>3.To determine about Antimicrobial activities in different solvents <br/ ><br>4.To find out primary phytochemical analysis in trial drug <br/ ><br>5.To evaluate spirometric changes in Iraippu Irumal <br/ ><br>6.To evaluate safety profile for acute and subacute toxicity <br/ ><br>7.To perform bio chemical analysisTimepoint: 45 days